Search This Blog

Wednesday, September 21, 2022

Sophia Genetics: 2 precision oncology pacts

 Investor day highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company 

SOPHiA GENETICS' next-generation solution CarePath, fueled by current real world observational data, was previewed for attendees

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.